Evaluation of the mechanisms for castration-resistance using CRPC tissues to predict the efficacy of Enzalutamide
Not Applicable
- Conditions
- Prostate cancer
- Registration Number
- JPRN-UMIN000019277
- Lead Sponsor
- Kyoto University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Male
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who are unable to receive prostate biopsy safely. Pathents with severe side effect by previous prostate biopsy. Allergy to Enzalutamide. Refuse the study. Age is younger than 20 years old.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method